活检设备市场:各市场区隔规模，占有率，法律规章，偿付，手术，2033年为止的预测

活检涉及从体内取出一块组织进行诊断或在显微镜下检查。活检装置是一种用于从体内取出组织样本的仪器。活检枪、真空辅助针装置、活检钳、活检穿孔器、活检针等均属于此类。

活检装置是一种用于从体内收集组织样本的装置。全球癌症发生率上升是活检设备市场的关键驱动因素之一。由于癌症病例在活检中占主导地位，因此该模型包含不同类型的癌症流行病学数据。然而，活检也适用于癌症以外的适应症，这种模型包括慢性肾臟病（CKD）、肝硬化和器官移植。在器官移植中，肾臟和肝臟移植被纳入分析，因为它们是最常进行的。

本报告提供全球活检设备市场相关资料详细考察，提供市场上竞争情形，SWOT分析，到2033年为止的市场预测，地区，各国的趋势等资讯。

目录

已上市的活检设备和不断变化的竞争格局

• 主要的产业趋势洞察
• 活检设备的各市场区隔整体市场收益和2015年～2033年的市场展望
• 各市场区隔的手术总数，台数，平均销售价格，市场价值相关详细资料

世界，地区，各国洞察

• 活检设备市场SWOT分析
• 活检设备市场相关竞争动态的洞察和趋势
• 各国医疗制度概要
• 各国偿付政策
• 各国医疗技术相关法规状况

Biopsy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within General Surgery Devices therapeutic area.

Biopsy entails the removal of some tissue from the body for the purpose of diagnosis or for its examination under a microscope. A Biopsy Device is an instrument that aids in the removal of tissue samples from the body. Biopsy Guns, Vacuum-Assisted Needle Devices, Biopsy Forceps, Biopsy Punches and Biopsy Needles are covered under this category.

A Biopsy Device is an instrument that aids in the removal of tissue samples from the body. Increasing global cancer incidence is one of the primary drivers of the biopsy devices market. As cancer cases dominate biopsy usage, various types of cancer epidemiology data have been included in this model. However, biopsies are also performed on non-cancerous indications, and those that have been included in this model are chronic kidney disease (CKD), liver cirrhosis, and organ transplantations. Within organ translanatations, kidney and liver transplantations were included for analysis as they are the most prevalent types.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Biopsy Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Biopsy Devices market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Biopsy Devices market.
• Competitive dynamics insights and trends provided for Biopsy Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Becton Dickinson and Co, Devicor Medical Products Inc, Hologic Inc, Cook Medical Inc, Boston Scientific Corp, Medtronic Plc, ConMed Corp, Olympus Corp, Argon Medical Devices Inc, Henry Schein Inc, Coloplast A/S, Merit Medical Systems Inc, Integra LifeSciences Holdings Corp, Teleflex Inc, Acuderm Inc, United States Endoscopy Group Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Biopsy Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Biopsy Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Biopsy Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Biopsy Devices market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.